Concomitant intake of quercetin with a grain-based diet acutely lowers postprandial plasma glucose and lipid concentrations in pigs

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wein, Silvia ^a   Wolffram, Siegfried ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FLAVONOID; GLUCOSE; LIPID; QUERCETIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ABSORPTION; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CROSSOVER PROCEDURE; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INGESTION; LIPID BLOOD LEVEL; MALE; NONHUMAN; STOMACH CONTENT; STOMACH EMPTYING; SWINE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANIMAL FOOD; AREA UNDER THE CURVE; CEREAL; CHEMISTRY; DRUG EFFECTS; NUTRITIONAL SCIENCE; PIG; POSTPRANDIAL STATE;

ANIMAL FEED; ANIMAL NUTRITION SCIENCES; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; CEREALS; GASTRIC EMPTYING; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; POSTPRANDIAL PERIOD; QUERCETIN; SWINE;

EID: 84899997017     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/748742     Document Type: Article

References (43)

1. Visscher T. L. S., Seidell J. C., The public health impact of obesity. Annual Review of Public Health 2001 22 355 375 2-s2.0-0035015194 10.1146/annurev.publhealth.22.1.355
2. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047
3. Standards of medical care in diabetes-2008. Diabetes Care 2008 31 supplement 1 S12 S54
4. Pang J., Chan D. C., Barrett P. H. R., Watts G. F., Postprandial dyslipidaemia and diabetes: mechanistic and therapeutic aspects. Current Opinion in Lipidology 2012 23 303 309
5. Pastromas S., Terzi A.-B., Tousoulis D., Koulouris S., Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. International Journal of Cardiology 2008 126 1 3 12 2-s2.0-41949113529 10.1016/j.ijcard.2007.04.172
6. Boden G., Laakso M., Lipids and glucose in type 2 diabetes: what is the cause and effect? Diabetes Care 2004 27 9 2253 2259 2-s2.0-4444344507 10.2337/diacare.27.9.2253
7. Miles J. M., Wooldridge D., Grellner W. J., Windsor S., Isley W. L., Klein S., Harris W. S., Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 2003 52 3 675 681 2-s2.0-0037339730 10.2337/diabetes.52.3.675
8. Tibaldi J., Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes. Southern Medical Journal 2009 102 1 60 66 2-s2.0-59249088492 10.1097/SMJ.0b013e318188898e
9. Vargas-Murga L., Garcia-Alvarez A., Roman-Viñas B., Ngo J., Ribas-Barba L., van den Berg S. J. P. L., Williamson G., Serra-Majem L., Plant food supplement (PFS) market structure in EC Member States, methods and techniques for the assessment of individual PFS intake. Food and Function 2011 2 12 731 739 2-s2.0-82455206252 10.1039/c1fo10075k
10. Kwon O., Eck P., Chen S., Corpe C. P., Lee J.-H., Kruhlak M., Levine M., Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB Journal 2007 21 2 366 377 2-s2.0-33846803914 10.1096/fj.06-6620com
11. Fang X.-K., Gao J., Zhu D.-N., Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sciences 2008 82 11-12 615 622 2-s2.0-39649087113 10.1016/j.lfs.2007.12.021
12. Kumazawa Y., Kawaguchi K., Takimoto H., Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor Current Pharmaceutical Design 2006 12 32 4271 4279 2-s2.0-33750567782 10.2174/138161206778743565
13. Naumann C., Bassler R., Seibold R. B. C., Die chemische Untersuchung von Futtermitteln. Methodenbuch Band III, Verband Deutscher Landwirtschaftlicher Untersuchungs Und Forschungsanstalten (VDLUFA) 1997 3 Darmstadt, Germany VDLUFA
14. Middleton E. Jr., Kandaswami C., Theoharides T. C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacological Reviews 2000 52 4 673 751 2-s2.0-0033637140
15. Graf B. A., Milbury P. E., Blumberg J. B., Flavonols, flavones, flavanones, and human health: epidemiological evidence. Journal of Medicinal Food 2005 8 3 281 290 2-s2.0-27144469821 10.1089/jmf.2005.8.281
16. Barnes J., Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: efficacy and safety. British Journal of Clinical Pharmacology 2003 55 4 331 340 2-s2.0-0038416708 10.1046/j.1365-2125. 2003.01811.x
17. Barnes J., Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. British Journal of Clinical Pharmacology 2003 55 3 226 233 2-s2.0-0037352439 10.1046/j.1365-2125.2003.01810.x
18. Middleton E., Biological properties of plant flavonoids: an overview. International Journal of Pharmacognosy 1996 34 5 344 348 2-s2.0-0030424076
19. Miller L. G., Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine 1998 158 20 2200 2211 2-s2.0-0032501120 10.1001/archinte.158.20.2200
20. Lesser S., Wolffram S., Oral bioavailability of the flavonol quercetin-a review. Current Topics in Nutraceutical Research 2006 4 3-4 239 256 2-s2.0-34247117650
21. Graf B. A., Mullen W., Caldwell S. T., Hartley R. C., Duthie G. G., Lean M. E. J., Crozier A., Edwards C. A., Disposition and metabolism of [2-14C]quercetin-4′- glucoside in rats. Drug Metabolism and Disposition 2005 33 7 1036 1043 2-s2.0-22344445695 10.1124/dmd.104.002691
22. Ader P., Wessmann A., Wolffram S., Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radical Biology and Medicine 2000 28 7 1056 1067 2-s2.0-0034108013 10.1016/S0891-5849(00)00195-7
23. Graefe E. U., Wittig J., Mueller S., Riethling A.-K., Uehleke B., Drewelow B., Pforte H., Jacobasch G., Derendorf H., Veit M., Pharmacokinetics and bioavailability of quercetin glycosides in humans. Journal of Clinical Pharmacology 2001 41 5 492 499 2-s2.0-17744396286 10.1177/00912700122010366
24. Reinboth M., Wolffram S., Abraham G., Ungemach F. R., Cermak R., Oral bioavailability of quercetin from different quercetin glycosides in dogs. British Journal of Nutrition 2010 104 2 198 203 2-s2.0-77955284662 10.1017/S000711451000053X
25. Wein S., Wolffram S., Oral bioavailability of quercetin in horses. Journal of Equine Veterinary Science 2013 33 441 445
26. Cazarolli L. H., Zanatta L., Alberton E. H., Figueiredo M. S. R. B., Folador P., Damazio R. G., Pizzolatti M. G., Silva F. R. M. B., Flavonoids: prospective drug candidates. Mini Reviews in Medicinal Chemistry 2008 8 13 1429 1440 2-s2.0-58149400667 10.2174/138955708786369564
27. Kim J.-H., Kang M.-J., Choi H.-N., Jeong S.-M., Lee Y.-M., Kim J.-I., Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutrition Research and Practice 2011 5 2 107 111 2-s2.0-79956273349 10.4162/nrp.2011.5.2.107
28. Li Y. Q., Zhou F. C., Gao F., Bian J. S., Shan F., Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of -glucosidase. Journal of Agricultural and Food Chemistry 2009 57 24 11463 11468 2-s2.0-73349100639 10.1021/jf903083h
29. Breuer H.-W. M., Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes. International Journal of Clinical Pharmacology and Therapeutics 2003 41 10 421 440 2-s2.0-0141996261
30. Kellett G. L., Brot-Laroche E., Mace O. J., Leturque A., Sugar absorption in the intestine: the role of GLUT2. Annual Review of Nutrition 2008 28 35 54 2-s2.0-50949090915 10.1146/annurev.nutr.28.061807.155518
31. Cermak R., Landgraf S., Wolffram S., Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. British Journal of Nutrition 2004 91 6 849 855 2-s2.0-3142549141 10.1079/BJN20041128
32. Song J., Kwon O., Chen S., Daruwala R., Eck P., Park J. B., Levine M., Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose. Journal of Biological Chemistry 2002 277 18 15252 15260 2-s2.0-0037013196 10.1074/jbc.M110496200
33. Baggio C. H., Freitas C. S., Mayer B., dos Santos A. C., Twardowschy A., Potrich F. B., Cipriani T. R., de Souza L. M., Sassaki G. L., Iacomini M., Marques M. C. A., Mesia-Vela S., Muscarinic-dependent inhibition of gastric emptying and intestinal motility by fractions of Maytenus ilicifolia Mart ex. Reissek. Journal of Ethnopharmacology 2009 123 3 385 391 2-s2.0-67349111783 10.1016/j.jep.2009.03.037
34. Chazova I. E., Mychka B. B., Metabolic syndrome treatment: focusing on acarbose. Cardiovascular Therapy and Prevention 2008 7 60 64
35. Brewer D., Are alpha-glucosidase inhibitors effective for control of type 2 diabetes? American Family Physician 2006 73 3 433 3 2-s2.0-32244437637
36. Derosa G., Maffioli P., Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review. Clinical Therapeutics 2012 34 1221 1236
37. Jenney A., Proietto J., O'Dea K., Nankervis A., Traianedes K., D'Embden H., Low-dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity. Diabetes Care 1993 16 2 499 502 2-s2.0-0027502311
38. Okada S., Ishii K., Tanokuchi S., Hamada H., Ichiki K., Ota Z., Effect of -glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus. Journal of International Medical Research 1995 23 6 492 496 2-s2.0-0029558002
39. Wein S., Behm N., Petersen R. K., Kristiansen K., Wolffram S., Quercetin enhances adiponectin secretion by a PPAR- γ independent mechanism. European Journal of Pharmaceutical Sciences 2010 41 1 16 22 2-s2.0-77954761550 10.1016/j.ejps.2010.05.004
40. Bok S.-H., Park S.-Y., Yong B. P., Lee M.-K., Jeon S.-M., Jeong T.-S., Choi M.-S., Quercetin dihydrate and gallate supplements lower plasma and hepatic lipids and change activities of hepatic antioxidant enzymes in high cholesterol-fed rats. International Journal for Vitamin and Nutrition Research 2002 72 3 161 169 2-s2.0-0035986786
41. Gabler N. K., Ostrowska E., Sterling S. J., Jones R. B., Tatham B. G., Eagling D. R., Jois M., Dunshea F. R., Consumption of raw brown onions variably modulate plasma lipid profile and lipoprotein oxidation in pigs fed a high-fat diet. Journal of the Science of Food and Agriculture 2005 85 1 154 160 2-s2.0-11244315676 10.1002/jsfa.1976
42. Pfeuffer M., Auinger A., Bley U., Kraus-Stojanowic I., Laue C., Winkler P., Rüfer C. E., Frank J., Bösch-Saadatmandi C., Rimbach G., Schrezenmeir J., Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammatory parameters in men with different APOE isoforms. Nutrition, Metabolism and Cardiovascular Diseases 2013 23 403 409 2-s2.0-81555234437 10.1016/j.numecd.2011.08.010
43. Sergent T., Vanderstraeten J., Winand J., Beguin P., Schneider Y. J., Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chemistry 2012 135 68 73